Infection Prevention and Control

SUBMENÚ

 
 

Multi-resistant pathogens cause increases in healthcare costs due to the demand for more expensive drugs and prolonged hospital stays. Multi-resistant drugs are responsible for increased morbidity and mortality of patients admitted to hospitals. These hospital-acquired infections affect the most fragile patients in intensive care units; oncology and neonatology, which often result in high mortality.

1

IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION AND CONTROL OF HEALTHCARE-ASSOCIATED INFECTIONS: ROAD MAP

This roadmap responds to a proposal from the Pan American Health Organization and has been designed to support the countries of the Americas in the implementation of infection prevention and control (PCI) programs associated with health care, in accordance with the guidelines of the World Health Organization (WHO).


 

PDF Version web version

Guidelines, Technical Documents and Training Courses


 

Back to Menu

 

Latest news

Stories

Documents

Communication Materials

Epidemiological Updates and Alerts

Mandates and Strategies

Events